Mao JT - Search Results

1

Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.

Mao JT, Roth MD, Serio KJ, Baratelli F, Zhu L, Holmes EC, Strieter RM, Dubinett SM. Mao JT, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5835-41. Clin Cancer Res. 2003. PMID: 14676104

2

All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema.

Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD. Mao JT, et al. Chest. 2003 Nov;124(5):1724-32. doi: 10.1378/chest.124.5.1724. Chest. 2003. PMID: 14605041 Clinical Trial.

3

Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.

Põld M, Zhu LX, Sharma S, Burdick MD, Lin Y, Lee PP, Põld A, Luo J, Krysan K, Dohadwala M, Mao JT, Batra RK, Strieter RM, Dubinett SM. Põld M, et al. Among authors: mao jt. Cancer Res. 2004 Mar 1;64(5):1853-60. doi: 10.1158/0008-5472.can-03-3262. Cancer Res. 2004. PMID: 14996749

4

Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.

Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM. Põld M, et al. Among authors: mao jt. Cancer Res. 2004 Sep 15;64(18):6549-55. doi: 10.1158/0008-5472.CAN-04-1225. Cancer Res. 2004. PMID: 15374967

5

Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.

Mao JT, Tsu IH, Dubinett SM, Adams B, Sarafian T, Baratelli F, Roth MD, Serio KJ. Mao JT, et al. Clin Cancer Res. 2004 Oct 15;10(20):6872-8. doi: 10.1158/1078-0432.CCR-04-0945. Clin Cancer Res. 2004. PMID: 15501964 Clinical Trial.

6

Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.

Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM. Mao JT, et al. Clin Lung Cancer. 2005 Jul;7(1):30-9. doi: 10.3816/CLC.2005.n.019. Clin Lung Cancer. 2005. PMID: 16098242 Review.

7

Celecoxib decreases Ki-67 proliferative index in active smokers.

Mao JT, Fishbein MC, Adams B, Roth MD, Goodglick L, Hong L, Burdick M, Strieter ER, Holmes C, Tashkin DP, Dubinett SM. Mao JT, et al. Clin Cancer Res. 2006 Jan 1;12(1):314-20. doi: 10.1158/1078-0432.CCR-05-1440. Clin Cancer Res. 2006. PMID: 16397057 Clinical Trial.

8

Differential modulation of leukotriene B4 synthesis and degradation in human bronchoalveolar lavage cells by lipopolysaccharide and tobacco smoke.

Mao JT, Tashkin DP, Tsu IH, Serio KJ. Mao JT, et al. Cancer Prev Res (Phila). 2008 Sep;1(4):266-74. doi: 10.1158/1940-6207.CAPR-08-0001. Cancer Prev Res (Phila). 2008. PMID: 19138970

9

Lung cancer chemoprevention with celecoxib in former smokers.

Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Mao JT, et al. Cancer Prev Res (Phila). 2011 Jul;4(7):984-93. doi: 10.1158/1940-6207.CAPR-11-0078. Cancer Prev Res (Phila). 2011. PMID: 21733822 Free PMC article. Clinical Trial.

10

Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM. Huang M, et al. Among authors: mao jt. Cancer Res. 1998 Mar 15;58(6):1208-16. Cancer Res. 1998. PMID: 9515807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters